Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

If PayPal Earnings Disappoint, This Investor Plans To Buy Nvidia And Coinbase: Here's Why

With PayPal Holdings Inc (NASDAQ: PYPL) down nearly 70% over the last year, disappointing earnings after the market closes Wednesday could be the last straw for one longtime investor.

Benzinga

Fake News About Fake Meat? Here's What's Going On With Beyond Meat Shares Today

Beyond Meat Inc (NASDAQ: BYND) shares are trading higher by 9.82% at $39.02 following a report from Fast Company indicating Beyond Meat-based McPlant burger will become a permanent menu item at McDonald’s (NYSE: MCD)

Benzinga

Some Celebrities Leave Twitter, Other Notables Return: What Investors Should Know

News that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk reached a deal to acquire Twitter Inc (NYSE: TWTR) has drawn mixed reactions from investors, Twitter users and celebrities.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Mid-Afternoon Market Update: Extreme Networks Drops After Q3 Results; Vivakor Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 300 points on Wednesday.

Benzinga

6 Microsoft Analysts Praise Q3 Earnings Beat, Azure Acceleration, Office 365 Momentum

Microsoft Corporation (NASDAQ: MSFT) shares traded higher by 7.2% on Wednesday after the company reported an across-the-board earnings beat and demonstrated impressive sales momentum.

Benzinga

Stocks That Hit 52-Week Lows On Wednesday

Wednesday's session saw 784 companies set new 52-week lows.

Benzinga

12 Information Technology Stocks Moving In Wednesday's Intraday Session

Benzinga

Read news from The Economist, FT, and more,
with one subscription

12 Industrials Stocks Moving In Wednesday's Intraday Session

Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga

10 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

Benzinga

Phishing Fleets Prowl Cyberspace Pretending To Be LinkedIn Messages: What You Need To Know

More than half of all recorded phishing assaults perpetrated during the first three months of the year involved cybercriminals pretending to send digital messages from LinkedIn, the social media platform division of Microsoft Corp. (NASDAQ: MSFT).

Benzinga

What Went Wrong At Meta Last Quarter And How Pete Najarian Is Positioning Ahead Of Earnings After The Bell

Meta Platforms Inc (NASDAQ: FB) shares are trading at 52-week lows Wednesday ahead of earnings after the bell.

Benzinga

A Preview Of Limelight Networks's Earnings

Limelight Networks (NASDAQ:LLNW) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Limelight Networks will report an earnings per share (EPS) of $-0.04.

Benzinga

Here's How Much You Would Have Made Owning F5 Stock In The Last 20 Years

F5 (NASDAQ:FFIV) has outperformed the market over the past 20 years by 11.42% on an annualized basis producing an average annual return of 18.59%. Currently, F5 has a market capitalization of $10.21 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Preview For T. Rowe Price Group

T. Rowe Price Group (NASDAQ:TROW) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that T. Rowe Price Group will report an earnings per share (EPS) of $2.74.

Benzinga

Earnings Preview: Stericycle

Stericycle (NASDAQ:SRCL) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Stericycle will report an earnings per share (EPS) of $0.46.

Benzinga

A Preview Of Abiomed's Earnings

Abiomed (NASDAQ:ABMD) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Abiomed will report an earnings per share (EPS) of $1.09.

Benzinga

How Is The Market Feeling About Nkarta Inc. - Common Stock?

Nkarta Inc. - Common Stock's (NASDAQ:NKTX) short percent of float has risen 8.05% since its last report. The company recently reported that it has 1.84 million shares sold short, which is 9.66% of all regular shares that are available for trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Jupiter Wellness To Offer Clinical Research Services With Acquisition Of Ascent Clinical Research

Jupiter Wellness, Inc. (NASDAQ: JUPW) has concluded an asset purchase agreement with Ascent Clinical Research, Inc.

Benzinga

10 Communication Services Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

Benzinga

Why Donald Trump-Related Stock Digital World Acquisition Is Rising

Digital World Acquisition Corp (NASDAQ: DWAC) shares are trading higher by 9.00% at $44.47 after Truth Social became the top free app on the App Store. Digital World Acquisition Corp is the merger partner of Trump Media & Technology Group, which is the owner of Truth Social.

Benzinga

Integra LifeSciences Posts Street Beating Earnings, Backs FY22 Guidance

Integra LifeSciences Holdings Corp (NASDAQ:IART) reported Q1 FY22 sales of $376.6 million, +4.6% Y/Y on a reported basis and 5.6% organic, beating the consensus of $362.04 million. Adjusted EPS stood at $0.74, ahead of The Street estimate of $0.68. Integra Lifesciences in Q1 also announced the launch of its NeuraGen 3D nerve guide matrix,…

Benzinga

Insulet Highlights New Data For Omnipod 5 System For Type 1, Type 2 Diabetes

Insulet Corporation (NASDAQ:PODD) unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes patients. Paired with DexCom Inc's (NASDAQ:DXCM) G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery system. Related: FDA Approves Insulet's Omnipod Automated Insulin Delivery System Patients…

Benzinga

8 Stocks Moved By Traders On Wednesday's CNBC's 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

1 … 617 618 619 620

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations